S6 Ep6: Biosimilars Policy Roundup for March 2023—Podcast Edition

Not So Different: A Podcast from The Center for Biosimilars

Show notes
Canadian Province Newfoundland and Labrador Adds Biosimilar Switching Policy
Yukon Becomes Tenth Canadian Jurisdiction to Add Biosimilars Switching Policy
Policy Recommendations for Improving Biosimilar Uptake in Belgium
Researchers Recommend Improvements for China’s Biosimilar Regulatory Policies
Dr Ivo Abraham Column: The 2022 WHO Biosimilar Guidelines—Loosening the Reins or Changing the Track? Part 2
The Increasing Access to Biosimilars Act of 2023 Introduced to Congress

Published Data Coupled With Real-world Evidence Show Safety of Biosimilar-to-Biosimilar Switching

Uptake Barriers Will Deter Future Competitors From Investing in Biosimilars, Julie Reed Warns